NCT06584383View on ClinicalTrials.gov

A Prospective, Randomized, Controlled Trial to Test Safety and Effectiveness of Unilateral Exablate MR-guided Focused Ultrasound Subthalamotomy in Patients With Early-Stage Parkinson's Disease

NARecruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2029

Conditions
Parkinson Disease
Interventions
PROCEDURE

Exablate MRgFUS subthalamotomy

Exablate MRgFUS subthalamotomy for Parkinson's Disease

DRUG

Best Medical Treatment

Subjects will be managed according to conventional therapeutic guidelines (i.e., best medical treatment) for Parkinson's Disease

Trial Locations (4)

24105

RECRUITING

Universitätsklinikum Schleswig-Holstein, Campus Kiel (UKSH), Kiel

28938

RECRUITING

HM CINAC- Hospital Universitario HM Puerta del Sur, Móstoles

31008

RECRUITING

Clinica Universidad de Navarra, Pamplona

Unknown

RECRUITING

Pontificia Universidad Catolica de Chile, Santiago

Sponsors

Lead Sponsor

InSightec
All Listed Sponsors
lead

InSightec

INDUSTRY

NCT06584383 - A Prospective, Randomized, Controlled Trial to Test Safety and Effectiveness of Unilateral Exablate MR-guided Focused Ultrasound Subthalamotomy in Patients With Early-Stage Parkinson's Disease | Biotech Hunter | Biotech Hunter